Fumi tweeted he was going in the direction of Gene Therapy for Wolfram's today. Recall, late last year, we started talks on selling the rights to MANF on the Gene Therapy side. As Fumi noted, and many of you know, what a hot space right now, especially with the telomere research the other day,